| Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor EA Walter, PD Greenberg, MJ Gilbert, RJ Finch, KS Watanabe, ... New England Journal of Medicine 333 (16), 1038-1044, 1995 | 2297 | 1995 |
| Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect … C Yee, JA Thompson, D Byrd, SR Riddell, P Roche, E Celis, ... Proceedings of the National Academy of Sciences 99 (25), 16168-16173, 2002 | 1637 | 2002 |
| Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones SR Riddell, KS Watanabe, JM Goodrich, CR Li, ME Agha, PD Greenberg Science 257 (5067), 238-241, 1992 | 1579 | 1992 |
| Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients PP Lee, C Yee, PA Savage, L Fong, D Brockstedt, JS Weber, D Johnson, ... Nature medicine 5 (6), 677-685, 1999 | 1373 | 1999 |
| Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development MA Gavin, TR Torgerson, E Houston, P DeRoos, WY Ho, ... Proceedings of the National Academy of Sciences 103 (17), 6659-6664, 2006 | 989 | 2006 |
| Facilitating matched pairing and expression of TCR chains introduced into human T cells J Kuball, ML Dossett, M Wolfl, WY Ho, RH Voss, C Fowler, PD Greenberg Blood 109 (6), 2331-2338, 2007 | 903 | 2007 |
| Cancer immunotherapy: a treatment for the masses JN Blattman, PD Greenberg Science 305 (5681), 200-205, 2004 | 883 | 2004 |
| Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, ... Blood, The Journal of the American Society of Hematology 112 (6), 2261-2271, 2008 | 848 | 2008 |
| Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells PD Greenberg Advances in immunology 49, 281-355, 1991 | 844 | 1991 |
| Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and … P Reusser, SR Riddell, JD Meyers, PD Greenberg | 818 | 1991 |
| Multiple early factors anticipate post-acute COVID-19 sequelae Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ... Cell 185 (5), 881-895. e20, 2022 | 790 | 2022 |
| Tolerance and exhaustion: defining mechanisms of T cell dysfunction A Schietinger, PD Greenberg Trends in immunology 35 (2), 51-60, 2014 | 714 | 2014 |
| T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients SR Riddell, M Elliott, DA Lewinsohn, MJ Gilbert, L Wilson, SA Manley, ... Nature medicine 2 (2), 216-223, 1996 | 706 | 1996 |
| Marrow transplantation for the treatment of chronic myelogenous leukemia ED THOMAS, RA CLIFT, A FEFER, FR APPELBAUM, P BEATTY, ... Annals of Internal Medicine 104 (2), 155-163, 1986 | 697 | 1986 |
| CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results BG Till, MC Jensen, J Wang, X Qian, AK Gopal, DG Maloney, ... Blood, The Journal of the American Society of Hematology 119 (17), 3940-3950, 2012 | 659 | 2012 |
| Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis A Schietinger, M Philip, VE Krisnawan, EY Chiu, JJ Delrow, RS Basom, ... Immunity 45 (2), 389-401, 2016 | 634 | 2016 |
| Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies KG Anderson, IM Stromnes, PD Greenberg Cancer cell 31 (3), 311-325, 2017 | 633 | 2017 |
| Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir … CR Li, PD Greenberg, MJ Gilbert, JM Goodrich, SR Riddell | 608 | 1994 |
| T cell receptor gene therapy for cancer TM Schmitt, GB Ragnarsson, PD Greenberg Human gene therapy 20 (11), 1240-1248, 2009 | 590 | 2009 |
| Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell–mediated vitiligo C Yee, JA Thompson, P Roche, DR Byrd, PP Lee, M Piepkorn, K Kenyon, ... The Journal of experimental medicine 192 (11), 1637-1644, 2000 | 565 | 2000 |
